Cite
HARVARD Citation
Spukti, E. et al. (2018). 90Y‐ibritumomab‐tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single‐center experience. European journal of haematology. pp. 514-521. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Spukti, E. et al. (2018). 90Y‐ibritumomab‐tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single‐center experience. European journal of haematology. pp. 514-521. [Online].